Psychiatric API - Global and China Top Players Market Share and Ranking 2023
This report studies and analyses global Psychiatric API status and future trends, helps the client to determine the Psychiatric API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Psychiatric API, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Psychiatric API market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Psychiatric API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Psychiatric API sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Psychiatric API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Psychiatric API key producing regions, capacity, production, and year over year growth
(6) Psychiatric API industry chains, upstream, midstream and downstream
According to Latest Research, the global market for Psychiatric API should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Psychiatric API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Psychiatric API market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Major Depressive Disorder grew percent to account for percent of the total market sales, and Generalized Anxiety Disorder grew percent.
Key Players Driving the Market:
Pfizer
Eli Lilly
Salutas Pharma
Bora Pharmaceutical
Dr.Reddy's Laboratories
Germany Pharmaceutical
Hengrui Pharmaceuticals
Herui Pharmaceutical
Ren An Pharmaceutical
Yaopharma
Kanghong Pharmaceutical
Brilliant Pharmaceutical
Dongting Pharmaceutical
Sichuan Chuanda West China Pharmaceutical
Yangtze River Pharmaceutical
Huahai Pharmaceutical
By Product Type, the market is primarily segmented into:
Venlafaxine
Duloxetine
Olanzapine
Paroxetine
Others
By Applications, the market is segmented into:
Major Depressive Disorder
Generalized Anxiety Disorder
Fibromyalgia
Schizophrenia
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Psychiatric API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Psychiatric API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Psychiatric API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Psychiatric API, percent & CAGR, 2018-2029
Chapter 5: Psychiatric API industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Psychiatric API Definition
1.2 Global Psychiatric API Market Size and Forecast
1.2.1 By Consumption Value, Global Psychiatric API Market Size，2018-2029
1.2.2 By Sales Quantity, Global Psychiatric API Market Size，2018-2029
1.2.3 Global Psychiatric API Average Selling Price (ASP)，2018-2029
1.3 China Psychiatric API Market Size and Forecast
1.3.1 By Consumption Value, China Psychiatric API Market Size，2018-2029
1.3.2 By Sales Quantity, China Psychiatric API Market Size，2018-2029
1.3.3 China Psychiatric API Average Selling Price (ASP)， 2018-2029
1.4 Share of China Psychiatric API Market with Respect to the Global Market
1.4.1 By Consumption Value, China Psychiatric API Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Psychiatric API Market Share in Global, 2018-2029
1.4.3 Psychiatric API Market Size: China VS Global, 2018-2029
1.5 Psychiatric API Market Dynamics
1.5.1 Psychiatric API Market Drivers
1.5.2 Psychiatric API Market Restraints
1.5.3 Psychiatric API Industry Trends
1.5.4 Psychiatric API Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Psychiatric API, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Psychiatric API, Global Market Share by Company, 2018-2023
2.3 Psychiatric API Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Psychiatric API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Psychiatric API Concentration Ratio
2.6 Global Psychiatric API Mergers & Acquisitions, Expansion Plans
2.7 Global Psychiatric API Manufacturers Product Type
2.8 Head Office and Psychiatric API Production Site of Key Manufacturer
2.9 Psychiatric API Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Psychiatric API, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Psychiatric API, China Market Share by Company, 2018-2023
3.3 China Psychiatric API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Psychiatric API Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Psychiatric API Capacity by Region
4.3 Global Psychiatric API Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Psychiatric API Production by Region, 2018-2029
4.5 Global Psychiatric API Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Psychiatric API Industry Chain
5.2 Psychiatric API Upstream Analysis
5.2.1 Psychiatric API Core Raw Materials
5.2.2 Main Manufacturers of Psychiatric API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Psychiatric API Production Mode
5.6 Psychiatric API Procurement Model
5.7 Psychiatric API Industry Sales Model and Sales Channels
5.7.1 Psychiatric API Sales Model
5.7.2 Psychiatric API Typical Distributors
6 Sights by Type
6.1 Psychiatric API Classification
6.1.1 Venlafaxine
6.1.2 Duloxetine
6.1.3 Olanzapine
6.1.4 Paroxetine
6.1.5 Others
6.2 By Type, Global Psychiatric API Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Psychiatric API Consumption Value, 2018-2029
6.4 By Type, Global Psychiatric API Sales Quantity, 2018-2029
6.5 By Type, Global Psychiatric API Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Psychiatric API Segment by Application
7.1.1 Major Depressive Disorder
7.1.2 Generalized Anxiety Disorder
7.1.3 Fibromyalgia
7.1.4 Schizophrenia
7.1.5 Others
7.2 By Application, Global Psychiatric API Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Psychiatric API Consumption Value, 2018-2029
7.4 By Application, Global Psychiatric API Sales Quantity, 2018-2029
7.5 By Application, Global Psychiatric API Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Psychiatric API Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Psychiatric API Consumption Value, 2018-2029
8.3 By Region, Global Psychiatric API Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Psychiatric API & Forecasts, 2018-2029
8.4.2 By Country, North America Psychiatric API Market Size Market Share
8.5 Europe
8.5.1 Europe Psychiatric API Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Psychiatric API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Psychiatric API Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Psychiatric API Market Size Market Share
8.7 South America
8.7.1 South America Psychiatric API Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Psychiatric API Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Psychiatric API Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Psychiatric API Consumption Value, 2018-2029
9.3 By Country, Global Psychiatric API Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Psychiatric API Market Size, 2018-2029
9.4.2 By Type, U.S. Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Psychiatric API Market Size, 2018-2029
9.5.2 By Type, Europe Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Psychiatric API Market Size, 2018-2029
9.6.2 By Type, China Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Psychiatric API Market Size, 2018-2029
9.7.2 By Type, Japan Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Psychiatric API Market Size, 2018-2029
9.8.2 By Type, South Korea Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Psychiatric API Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Psychiatric API Market Size, 2018-2029
9.10.2 By Type, India Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Psychiatric API Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Psychiatric API Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Psychiatric API Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.1.2 Pfizer Psychiatric API Models, Specifications, and Application
10.1.3 Pfizer Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
10.2.2 Eli Lilly Psychiatric API Models, Specifications, and Application
10.2.3 Eli Lilly Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Eli Lilly Company Profile and Main Business
10.2.5 Eli Lilly Recent Developments
10.3 Salutas Pharma
10.3.1 Salutas Pharma Company Information, Head Office, Market Area, and Industry Position
10.3.2 Salutas Pharma Psychiatric API Models, Specifications, and Application
10.3.3 Salutas Pharma Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Salutas Pharma Company Profile and Main Business
10.3.5 Salutas Pharma Recent Developments
10.4 Bora Pharmaceutical
10.4.1 Bora Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bora Pharmaceutical Psychiatric API Models, Specifications, and Application
10.4.3 Bora Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Bora Pharmaceutical Company Profile and Main Business
10.4.5 Bora Pharmaceutical Recent Developments
10.5 Dr.Reddy's Laboratories
10.5.1 Dr.Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
10.5.2 Dr.Reddy's Laboratories Psychiatric API Models, Specifications, and Application
10.5.3 Dr.Reddy's Laboratories Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Dr.Reddy's Laboratories Company Profile and Main Business
10.5.5 Dr.Reddy's Laboratories Recent Developments
10.6 Germany Pharmaceutical
10.6.1 Germany Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Germany Pharmaceutical Psychiatric API Models, Specifications, and Application
10.6.3 Germany Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Germany Pharmaceutical Company Profile and Main Business
10.6.5 Germany Pharmaceutical Recent Developments
10.7 Hengrui Pharmaceuticals
10.7.1 Hengrui Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.7.2 Hengrui Pharmaceuticals Psychiatric API Models, Specifications, and Application
10.7.3 Hengrui Pharmaceuticals Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Hengrui Pharmaceuticals Company Profile and Main Business
10.7.5 Hengrui Pharmaceuticals Recent Developments
10.8 Herui Pharmaceutical
10.8.1 Herui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Herui Pharmaceutical Psychiatric API Models, Specifications, and Application
10.8.3 Herui Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Herui Pharmaceutical Company Profile and Main Business
10.8.5 Herui Pharmaceutical Recent Developments
10.9 Ren An Pharmaceutical
10.9.1 Ren An Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.9.2 Ren An Pharmaceutical Psychiatric API Models, Specifications, and Application
10.9.3 Ren An Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Ren An Pharmaceutical Company Profile and Main Business
10.9.5 Ren An Pharmaceutical Recent Developments
10.10 Yaopharma
10.10.1 Yaopharma Company Information, Head Office, Market Area, and Industry Position
10.10.2 Yaopharma Psychiatric API Models, Specifications, and Application
10.10.3 Yaopharma Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Yaopharma Company Profile and Main Business
10.10.5 Yaopharma Recent Developments
10.11 Kanghong Pharmaceutical
10.11.1 Kanghong Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Kanghong Pharmaceutical Psychiatric API Models, Specifications, and Application
10.11.3 Kanghong Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Kanghong Pharmaceutical Company Profile and Main Business
10.11.5 Kanghong Pharmaceutical Recent Developments
10.12 Brilliant Pharmaceutical
10.12.1 Brilliant Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.12.2 Brilliant Pharmaceutical Psychiatric API Models, Specifications, and Application
10.12.3 Brilliant Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Brilliant Pharmaceutical Company Profile and Main Business
10.12.5 Brilliant Pharmaceutical Recent Developments
10.13 Dongting Pharmaceutical
10.13.1 Dongting Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Dongting Pharmaceutical Psychiatric API Models, Specifications, and Application
10.13.3 Dongting Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Dongting Pharmaceutical Company Profile and Main Business
10.13.5 Dongting Pharmaceutical Recent Developments
10.14 Sichuan Chuanda West China Pharmaceutical
10.14.1 Sichuan Chuanda West China Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Sichuan Chuanda West China Pharmaceutical Psychiatric API Models, Specifications, and Application
10.14.3 Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sichuan Chuanda West China Pharmaceutical Company Profile and Main Business
10.14.5 Sichuan Chuanda West China Pharmaceutical Recent Developments
10.15 Yangtze River Pharmaceutical
10.15.1 Yangtze River Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Yangtze River Pharmaceutical Psychiatric API Models, Specifications, and Application
10.15.3 Yangtze River Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Yangtze River Pharmaceutical Company Profile and Main Business
10.15.5 Yangtze River Pharmaceutical Recent Developments
10.16 Huahai Pharmaceutical
10.16.1 Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.16.2 Huahai Pharmaceutical Psychiatric API Models, Specifications, and Application
10.16.3 Huahai Pharmaceutical Psychiatric API Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Huahai Pharmaceutical Company Profile and Main Business
10.16.5 Huahai Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Psychiatric API Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Psychiatric API Market Restraints
Table 3. Psychiatric API Market Trends
Table 4. Psychiatric API Industry Policy
Table 5. Global Psychiatric API Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Psychiatric API Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Psychiatric API Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Psychiatric API Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Psychiatric API Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Psychiatric API Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Psychiatric API Mergers & Acquisitions, Expansion Plans
Table 12. Global Psychiatric API Manufacturers Product Type
Table 13. Head Office and Psychiatric API Production Site of Key Manufacturer
Table 14. Psychiatric API Capacity of Major Manufacturers and Future Plan
Table 15. China Psychiatric API Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Psychiatric API Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Psychiatric API Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Psychiatric API Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Psychiatric API Production by Region, 2018-2023, (K Units)
Table 20. Global Psychiatric API Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Psychiatric API Upstream (Raw Materials)
Table 22. Global Psychiatric API Typical Customers
Table 23. Psychiatric API Typical Distributors
Table 24. By Type, Global Psychiatric API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Psychiatric API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Psychiatric API Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Psychiatric API Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Psychiatric API Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Psychiatric API Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Psychiatric API Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Psychiatric API Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Psychiatric API Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Psychiatric API Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Psychiatric API Models, Specifications, and Application
Table 36. Pfizer Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. Eli Lilly Company Information, Head Office, Market Area, and Industry Position
Table 40. Eli Lilly Psychiatric API Models, Specifications, and Application
Table 41. Eli Lilly Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Eli Lilly Company Profile and Main Business
Table 43. Eli Lilly Recent Developments
Table 44. Salutas Pharma Company Information, Head Office, Market Area, and Industry Position
Table 45. Salutas Pharma Psychiatric API Models, Specifications, and Application
Table 46. Salutas Pharma Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Salutas Pharma Company Profile and Main Business
Table 48. Salutas Pharma Recent Developments
Table 49. Bora Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 50. Bora Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 51. Bora Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Bora Pharmaceutical Company Profile and Main Business
Table 53. Bora Pharmaceutical Recent Developments
Table 54. Dr.Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 55. Dr.Reddy's Laboratories Psychiatric API Models, Specifications, and Application
Table 56. Dr.Reddy's Laboratories Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Dr.Reddy's Laboratories Company Profile and Main Business
Table 58. Dr.Reddy's Laboratories Recent Developments
Table 59. Germany Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 60. Germany Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 61. Germany Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Germany Pharmaceutical Company Profile and Main Business
Table 63. Germany Pharmaceutical Recent Developments
Table 64. Hengrui Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 65. Hengrui Pharmaceuticals Psychiatric API Models, Specifications, and Application
Table 66. Hengrui Pharmaceuticals Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Hengrui Pharmaceuticals Company Profile and Main Business
Table 68. Hengrui Pharmaceuticals Recent Developments
Table 69. Herui Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 70. Herui Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 71. Herui Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Herui Pharmaceutical Company Profile and Main Business
Table 73. Herui Pharmaceutical Recent Developments
Table 74. Ren An Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 75. Ren An Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 76. Ren An Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Ren An Pharmaceutical Company Profile and Main Business
Table 78. Ren An Pharmaceutical Recent Developments
Table 79. Yaopharma Company Information, Head Office, Market Area, and Industry Position
Table 80. Yaopharma Psychiatric API Models, Specifications, and Application
Table 81. Yaopharma Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Yaopharma Company Profile and Main Business
Table 83. Yaopharma Recent Developments
Table 84. Kanghong Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Kanghong Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 86. Kanghong Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Kanghong Pharmaceutical Company Profile and Main Business
Table 88. Kanghong Pharmaceutical Recent Developments
Table 89. Brilliant Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 90. Brilliant Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 91. Brilliant Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Brilliant Pharmaceutical Company Profile and Main Business
Table 93. Brilliant Pharmaceutical Recent Developments
Table 94. Dongting Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 95. Dongting Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 96. Dongting Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Dongting Pharmaceutical Company Profile and Main Business
Table 98. Dongting Pharmaceutical Recent Developments
Table 99. Sichuan Chuanda West China Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 100. Sichuan Chuanda West China Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 101. Sichuan Chuanda West China Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Sichuan Chuanda West China Pharmaceutical Company Profile and Main Business
Table 103. Sichuan Chuanda West China Pharmaceutical Recent Developments
Table 104. Yangtze River Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 105. Yangtze River Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 106. Yangtze River Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Yangtze River Pharmaceutical Company Profile and Main Business
Table 108. Yangtze River Pharmaceutical Recent Developments
Table 109. Huahai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 110. Huahai Pharmaceutical Psychiatric API Models, Specifications, and Application
Table 111. Huahai Pharmaceutical Psychiatric API Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Huahai Pharmaceutical Company Profile and Main Business
Table 113. Huahai Pharmaceutical Recent Developments
List of Figures
Figure 1. Psychiatric API Picture
Figure 2. Global Psychiatric API Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Psychiatric API Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Psychiatric API Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Psychiatric API Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Psychiatric API Sales Quantity (K Units) & (2018-2029)
Figure 7. China Psychiatric API Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Psychiatric API Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Psychiatric API Market Share of Global, 2018-2029
Figure 10. Global Psychiatric API Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Psychiatric API Key Participants, Market Share, 2022
Figure 12. Global Psychiatric API Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Psychiatric API Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Psychiatric API Production Market Share & Forecast by Region, 2018-2029
Figure 15. Psychiatric API Industry Chain
Figure 16. Psychiatric API Procurement Model
Figure 17. Psychiatric API Sales Model
Figure 18. Psychiatric API Sales Channels, Direct Sales, and Distribution
Figure 19. Venlafaxine
Figure 20. Duloxetine
Figure 21. Olanzapine
Figure 22. Paroxetine
Figure 23. Others
Figure 24. By Type, Global Psychiatric API Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Psychiatric API Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Psychiatric API Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Psychiatric API Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Major Depressive Disorder
Figure 30. Generalized Anxiety Disorder
Figure 31. Fibromyalgia
Figure 32. Schizophrenia
Figure 33. Others
Figure 34. By Application, Global Psychiatric API Consumption Value, 2018-2029, US$ Million
Figure 35. By Application, Global Psychiatric API Consumption Value Market Share, 2018-2029
Figure 36. By Application, Global Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 37. By Application, Global Psychiatric API Sales Quantity Market Share, 2018-2029
Figure 38. By Application, Global Psychiatric API Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 39. By Region, Global Psychiatric API Consumption Value Market Share, 2018-2029
Figure 40. By Region, Global Psychiatric API Sales Quantity Market Share, 2018-2029
Figure 41. North America Psychiatric API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Psychiatric API Consumption Value Market Share, 2022
Figure 43. Europe Psychiatric API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Psychiatric API Consumption Value Market Share, 2022
Figure 45. Asia Pacific Psychiatric API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Psychiatric API Consumption Value Market Share, 2022
Figure 47. South America Psychiatric API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Psychiatric API Consumption Value Market Share, 2022
Figure 49. Middle East & Africa Psychiatric API Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, U.S. Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 53. Europe Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Europe Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Europe Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 56. China Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, China Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, China Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 59. Japan Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Japan Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Japan Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 62. South Korea Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, South Korea Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, South Korea Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 65. Southeast Asia Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Southeast Asia Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Southeast Asia Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 68. India Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, India Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, India Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 71. Middle East & Africa Psychiatric API Sales Quantity, 2018-2029, (K Units)
Figure 72. By Type, Middle East & Africa Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 73. By Application, Middle East & Africa Psychiatric API Sales Quantity Market Share, 2022 VS 2029
Figure 74. Research Methodology
Figure 75. Breakdown of Primary Interviews
Figure 76. Bottom-up and Top-down Approaches
Figure 77. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|